Offchain Labs boosts its ARB holdings, signaling confidence in Arbitrum as governance tokens slide and Ethereum layer-2 competition heats up.

Blood cells grown in a laboratory have been given to people for the first time in a clinical trial being carried out by researchers in the UK, in the hope that plentiful supplies of rare blood groups ...